The most common form of familial ALS (FALS) is due to mutations in the Cu.Zn superoxide dismutase (SOD1) gene. SOD1-FALS is caused by a """"""""toxic gain of function"""""""". Mitochondrial dysfunction has been demonstrated in SOD1-FALS models, and a growing body of evidence suggests that it may play a role in the pathogenesis of the disease. Although the majority of SOD1 resides in the cytosol, a significant proportion of SOD1 is localized in the mitochondria. The pathological role of mitochondrial SOD1 in FALS remains to be clarified. We propose to investigate the involvement of mitochondrial SOD1 in mitochondrial dysfunction and its role in the pathogenesis of SOD1-FALS. 1) Mitochondrial dysfunction, potentially resulting in energy depletion and apoptosis, has been observed in transgenic mice expressing mutant SOD1. To determine if mutant SOD1 localized in mitochondria causes mitochondrial dysfunction we will study neuronal cells expressing mutant or wild type SOD1 selectively targeted to mitochondria by specific cleavable protein targeting sequences. 2) To determine whether mitochondrial dysfunction associated with FALS is directly caused by mutant SOD1 in mitochondria and whether the selective expression of mutant SOD1 in mitochondria results in a pathological phenotype in vivo we will generate and study transgenic mice expressing mutant or wild type SOD1 targeted to mitochondria by specific cleavable protein targeting sequences. 3) Very little is known about the mechanisms underlying import of SOD1 in mammalian mitochondria. We will investigate: A) the molecular mechanisms involved in SOD1 mitochondrial import in affected and unaffected tissues; B) which protein domains are implicated in SOD1 mitochondrial import; C) the impact of SOD1 post-translational modifications and conformation on mitochondrial import. 4) Preliminary results suggest that SOD1 interacts with other mitochondrial proteins. A) Proteins with mitochondrial isoforms have been shown to interact with mutant but not wild type SOD1 in a yeast two- hybrid system. We will study these interactions in mammalian cells. B) We will search for novel protein interactions between SOD1 and mitochondrial proteins. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS051419-03
Application #
7413277
Study Section
Special Emphasis Panel (ZRG1-CDIN-D (01))
Program Officer
Refolo, Lorenzo
Project Start
2006-05-01
Project End
2010-04-30
Budget Start
2008-05-01
Budget End
2009-04-30
Support Year
3
Fiscal Year
2008
Total Cost
$293,630
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Neurology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Manfredi, Giovanni; Kawamata, Hibiki (2016) Mitochondria and endoplasmic reticulum crosstalk in amyotrophic lateral sclerosis. Neurobiol Dis 90:35-42
Palomo, Gloria M; Manfredi, Giovanni (2015) Exploring new pathways of neurodegeneration in ALS: the role of mitochondria quality control. Brain Res 1607:36-46
Magrané, Jordi; Cortez, Czrina; Gan, Wen-Biao et al. (2014) Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet 23:1413-24
Papa, Luena; Manfredi, Giovanni; Germain, Doris (2014) SOD1, an unexpected novel target for cancer therapy. Genes Cancer 5:15-21
Kawamata, Hibiki; Ng, Seng Kah; Diaz, Natalia et al. (2014) Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J Neurosci 34:2331-48
Kirk, Kathryne; Gennings, Chris; Hupf, Jonathan C et al. (2014) Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol 76:620-4
Peixoto, Pablo M; Kim, Hyun-Jeong; Sider, Brittany et al. (2013) UCP2 overexpression worsens mitochondrial dysfunction and accelerates disease progression in a mouse model of amyotrophic lateral sclerosis. Mol Cell Neurosci 57:104-10
Turner, Martin R; Bowser, Robert; Bruijn, Lucie et al. (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14 Suppl 1:19-32
Kim, Hyun Jeong; Magranè, Jordi; Starkov, Anatoly A et al. (2012) The mitochondrial calcium regulator cyclophilin D is an essential component of oestrogen-mediated neuroprotection in amyotrophic lateral sclerosis. Brain 135:2865-74
Magrané, Jordi; Sahawneh, Mary Anne; Przedborski, Serge et al. (2012) Mitochondrial dynamics and bioenergetic dysfunction is associated with synaptic alterations in mutant SOD1 motor neurons. J Neurosci 32:229-42

Showing the most recent 10 out of 20 publications